The Wall Street Journal published a lengthy deep dive into President Joe Biden's decline. Here are the five biggest ...
The editorial board said ‘there are bad omens here for 2025’ and questioned the ‘ability of Republicans to govern’ ...
Debunking claims of safety concerns around Zoetis Inc.'s OA pain drug, Librela. Click here for our updated look at ZTS stock ...
Following a last-minute deal in the House which kept the government running until March, the editorial board of the Wall ...
Consumers aren't quite feeling the holiday spirit. The consumer-confidence index declined by 8.1 points in December to 104.7, the Conference Board said Monday. Economists had expected an increase, ...
Some of the largest, most powerful companies in the United States are racing to finance President-elect Donald Trump's ...
The S&P 500 is in a raging bull market. It's up 26% in 2024, which followed a 26% gain in 2023. It hasn't delivered ...
Wall Street’s grinding office culture has pushed young bankers to resort to snorting lines of crushed Adderall pills from ...
Pensiero will report to Murray, her longtime colleague at the Wall Street Journal. Pensiero was managing editor from 2017 to ...
Gerry Baker is Editor at Large of The Wall Street Journal. His weekly column for the editorial page, “Free Expression,” appears in The Wall Street Journal each Tuesday. Mr. Baker is also host ...
Young Wall Street bankers working 90 hours a week are snorting lines of Adderall at their desks in a new office drug culture.
The semiconductor industry is the beating heart of the artificial intelligence (AI) revolution. Most investors are focused on ...